pentylenetetrazole has been researched along with cannabidiol in 19 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (26.32) | 18.7374 |
1990's | 1 (5.26) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 6 (31.58) | 24.3611 |
2020's | 7 (36.84) | 2.80 |
Authors | Studies |
---|---|
Consroe, PF; Wolkin, AL | 1 |
Borys, HK; Chiu, P; Karler, R; Turkanis, SA | 1 |
Browne, SE; Pertwee, RG; Ross, TM; Stretton, CD | 1 |
Calder, LD; Karler, R; Murphy, V; Turkanis, SA | 1 |
Calder, LD; Karler, R; Turkanis, SA | 1 |
Karler, R; Turkanis, SA | 1 |
Bevan, SA; Hill, AJ; Jones, NA; Smith, I; Stephens, GJ; Whalley, BJ; Williams, CM | 1 |
Ahmad-Molaei, L; Motamedi, F; Naderi, N; Shirazi-zand, Z | 1 |
Cascio, MG; Duncan, M; Hill, AJ; Hill, TD; Pertwee, RG; Romano, B; Whalley, BJ; Williams, CM | 1 |
Hill, AJ; Hill, CL; Jones, NA; Smith, I; Stephens, GJ; Whalley, BJ; Williams, CM | 1 |
Larson, C; López, HH; Pelz, MC; Schoolcraft, KD; Spring, MG | 1 |
Dallas, ML; Hafezi, N; Hu, Y; Mascal, M; Serra, G; Spencer, JPE; Wang, D | 1 |
Amsalem, K; Berman, P; Gelfand, A; Lewitus, DY; Lewitus, GM; Meiri, D; Uziel, A | 1 |
Ashpole, NM; Carty, DR; Dickson, KE; Thornton, C; Willett, KL | 1 |
Hložek, T; Kubová, H; Mareš, P; Páleníček, T; Uttl, L | 1 |
Barbosa da Silva, R; Carlini, E; Faber, J; Filev, R; Gimenes, C; Hashiguchi, D; Janisset, NRLL; Longo, BM; Quintella, ML; Romariz, SAA; Yokoyama, T | 1 |
Bellozi, PMQ; da Silva, MCM; de Assis Lima, IV; de Oliveira, ACP; Moraes, MFD; Moreira, FA; Pinto, HPP; Vilela, LR | 1 |
Forcelli, PA; Quinlan, S; Witherspoon, E | 1 |
He, M; Jiang, X; Lu, H; Wang, Q; Wei, M; Zhao, Y | 1 |
1 review(s) available for pentylenetetrazole and cannabidiol
Article | Year |
---|---|
Changes in CNS sensitivity to cannabinoids with repeated treatment: tolerance and auxoesthesia.
Topics: Animals; Brain; Cannabidiol; Cannabinoids; Dronabinol; Drug Tolerance; Electroshock; Kindling, Neurologic; Mice; Pentylenetetrazole; Phenytoin; Picrotoxin; Seizures | 1984 |
18 other study(ies) available for pentylenetetrazole and cannabidiol
Article | Year |
---|---|
Anticonvulsant interaction of cannabidiol and ethosuximide in rats.
Topics: Animals; Anticonvulsants; Cannabidiol; Cannabinoids; Drug Interactions; Ethosuximide; Male; Pentylenetetrazole; Proadifen; Rats | 1977 |
Influence of delta9-tetrahydrocannabinol and cannabidiol on photically evoked after-discharge potentials.
Topics: Animals; Anticonvulsants; Cannabidiol; Cannabinoids; Dose-Response Relationship, Drug; Dronabinol; Evoked Potentials; Male; Pentylenetetrazole; Photic Stimulation; Rats; Time Factors | 1977 |
An investigation of the involvement of GABA in certain pharmacological effects of delta-9-tetrahydrocannabinol.
Topics: Amino Acids; Amino Acids, Neutral; Analgesics; Animals; Anticonvulsants; Body Temperature; Cannabidiol; Dronabinol; Electric Stimulation; Flurazepam; gamma-Aminobutyric Acid; Guinea Pigs; In Vitro Techniques; Male; Mice; Muscle Contraction; Muscle, Smooth; Nipecotic Acids; Pentylenetetrazole; Seizures; Tiagabine | 1991 |
Pentylenetetrazol kindling in mice.
Topics: Animals; Anticonvulsants; Aspartic Acid; Brain; Cannabidiol; Electric Stimulation; Kindling, Neurologic; Male; Mice; N-Methylaspartate; Neurotransmitter Agents; Pentylenetetrazole; Picrotoxin | 1989 |
Excitatory and depressant effects of delta 9-tetrahydrocannabinol and cannabidiol on cortical evoked responses in the conscious rat.
Topics: Animals; Anticonvulsants; Cannabidiol; Cannabinoids; Cerebral Cortex; Convulsants; Dronabinol; Ethosuximide; Evoked Potentials; Pentylenetetrazole; Phenytoin; Rats; Rats, Inbred Strains | 1981 |
Cannabidiol displays antiepileptiform and antiseizure properties in vitro and in vivo.
Topics: 4-Aminopyridine; Action Potentials; Animals; Anticonvulsants; Cannabidiol; Disease Models, Animal; Female; Guanosine 5'-O-(3-Thiotriphosphate); Hippocampus; In Vitro Techniques; Magnesium; Male; Pentylenetetrazole; Rats; Rats, Inbred WKY; Receptor, Cannabinoid, CB1; Seizures | 2010 |
The role of potassium BK channels in anticonvulsant effect of cannabidiol in pentylenetetrazole and maximal electroshock models of seizure in mice.
Topics: Analysis of Variance; Animals; Anticonvulsants; Cannabidiol; Convulsants; Disease Models, Animal; Dose-Response Relationship, Drug; Electroshock; Indoles; Injections, Intraventricular; Large-Conductance Calcium-Activated Potassium Channels; Male; Mice; Pentylenetetrazole; Potassium Channel Blockers; Seizures | 2013 |
Cannabidivarin-rich cannabis extracts are anticonvulsant in mouse and rat via a CB1 receptor-independent mechanism.
Topics: Animals; Anticonvulsants; Brain; Cannabidiol; Cannabinoids; Cannabis; Disease Models, Animal; Dose-Response Relationship, Drug; Hand Strength; Male; Mice; Mice, Inbred DBA; Motor Activity; Noise; Pentylenetetrazole; Phytotherapy; Pilocarpine; Plant Extracts; Plants, Medicinal; Protein Binding; Rats; Rats, Inbred WKY; Receptor, Cannabinoid, CB1; Seizures | 2013 |
Voltage-gated sodium (NaV) channel blockade by plant cannabinoids does not confer anticonvulsant effects per se.
Topics: Animals; Anticonvulsants; Cannabidiol; Cannabinoids; Cells, Cultured; Cerebral Cortex; Cricetulus; Female; Hippocampus; Humans; In Vitro Techniques; Male; Mice; Neurons; Patch-Clamp Techniques; Pentylenetetrazole; Rats, Inbred WKY; Seizures; Voltage-Gated Sodium Channel Blockers | 2014 |
Assessing the role of serotonergic receptors in cannabidiol's anticonvulsant efficacy.
Topics: Animals; Anticonvulsants; Cannabidiol; Fluorobenzenes; Male; Pentylenetetrazole; Piperazines; Piperidines; Pyridines; Rats; Rats, Inbred WKY; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Seizures; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT2 Receptor Antagonists; Treatment Outcome | 2017 |
Synthetic, non-intoxicating 8,9-dihydrocannabidiol for the mitigation of seizures.
Topics: Animals; Anticonvulsants; Cannabidiol; Cannabinoids; Disease Models, Animal; Male; Pentylenetetrazole; Rats; Rats, Wistar; Seizures; Treatment Outcome | 2019 |
Full-Spectrum
Topics: Animals; Anticonvulsants; Cannabidiol; Cannabis; Delayed-Action Preparations; Drug Liberation; Mice; Pentylenetetrazole; Plant Extracts; Seizures | 2020 |
Cannabis constituents reduce seizure behavior in chemically-induced and scn1a-mutant zebrafish.
Topics: Acyclic Monoterpenes; Animals; Animals, Genetically Modified; Anticonvulsants; Cannabidiol; Cannabinoids; Cannabinol; Cannabis; Dose-Response Relationship, Drug; Dronabinol; NAV1.1 Voltage-Gated Sodium Channel; Pentylenetetrazole; Seizures; Zebrafish; Zebrafish Proteins | 2020 |
Anticonvulsive Effects and Pharmacokinetic Profile of Cannabidiol (CBD) in the Pentylenetetrazol (PTZ) or N-Methyl-D-Aspartate (NMDA) Models of Seizures in Infantile Rats.
Topics: Animals; Anticonvulsants; Brain; Cannabidiol; Disease Models, Animal; Epilepsy; Male; N-Methylaspartate; Pentylenetetrazole; Rats; Rats, Wistar; Seizures | 2021 |
Partial protective effects of cannabidiol against PTZ-induced acute seizures in female rats during the proestrus-estrus transition.
Topics: Animals; Anticonvulsants; Cannabidiol; Disease Models, Animal; Estrus; Female; Humans; Male; Pentylenetetrazole; Proestrus; Rats; Seizures | 2022 |
Cannabidiol effect in pentylenetetrazole-induced seizures depends on PI3K.
Topics: Animals; Anticonvulsants; Cannabidiol; Mice; Pentylenetetrazole; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Seizures | 2022 |
Preclinical efficacy of cannabidiol for the treatment of early-life seizures.
Topics: Animals; Anticonvulsants; Cannabidiol; Disease Models, Animal; Epilepsy; Pentylenetetrazole; Rats | 2022 |
The Potential Mechanism of Cannabidiol (CBD) Treatment of Epilepsy in Pentetrazol (PTZ) Kindling Mice Uncovered by Multi-Omics Analysis.
Topics: Animals; Anticonvulsants; Cannabidiol; Epilepsy; Mice; Multiomics; Pentylenetetrazole; Seizures | 2023 |